Literature DB >> 28374119

Sentinel lymph node mapping using SPECT/CT and gamma probe in endometrial cancer: an analysis of parameters affecting detection rate.

Samine Sahbai1, Florin-Andrei Taran2, Annette Staebler3, Diethelm Wallwiener2, Christian la Fougère4, Sara Brucker2, Helmut Dittmann4.   

Abstract

PURPOSE: SPECT/CT after pericervical injection of technetium-99 m-nanocolloid was shown to be suitable for sentinel lymph node (SLN) mapping in endometrial cancer (EC). The aim of this study was to analyze factors affecting successful SLN detection by means of SPECT/CT such as imaging findings, patient characteristics and tumor biology in a large cohort of patients.
METHODS: One hundred and forty-five consecutive patients suffering from EC who received pre-surgical SLN mapping at our institution between 2011 and 2016 were included in this analysis. SPECT/CT data of abdomen and pelvis (mean 4:20 ± 1:20 h p.i.) were acquired after pericervical injection of technetium-99 m-nanocolloid (mean 230 ± 45 MBq) in all patients. Surgical staging was performed on the day after. Acquisition parameters, patient characteristics, SPECT/CT findings as well as histopathological results were collected.
RESULTS: A total of 282 SLNs were identified by means of SPECT/CT. Overall, preoperative and intraoperative SLN detection rates were 86%, 76% and 74% respectively. The most important factor associated with failure to detect SLNs was the presence of high bone marrow on SPECT/CT (p = 0.005). Peritoneal/abdominal radioactivity was also associated with missed SLN detection in SPECT/CT (p = 0.02). However, the presence of liver/spleen uptake on its own was not predictive for detection failure. Low numbers of detected SLNs in SPECT/CT were slightly related with older age and lower injected activity. No significant influence was found for the parameters of tumor histology and stage, lymph node involvement and the time gap between injection and imaging.
CONCLUSIONS: Venous drainage as indicated by bone marrow uptake is the most important factor associated with scintigraphic SLN detection failure. Moreover, high peritoneal and abdominal activity was also associated with detection failure. Thus, meticulous application of the radiotracer is crucial in EC.

Entities:  

Keywords:  Detection failure; Endometrial cancer; Lymphoscintigraphy; Nanocolloid; SPECT/CT; Sentinel lymph node

Mesh:

Substances:

Year:  2017        PMID: 28374119     DOI: 10.1007/s00259-017-3692-6

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  37 in total

Review 1.  Meta-analysis of superficial versus deep injection of radioactive tracer and blue dye for lymphatic mapping and detection of sentinel lymph nodes in breast cancer.

Authors:  M Ahmed; A D Purushotham; K Horgan; J M Klaase; M Douek
Journal:  Br J Surg       Date:  2014-12-16       Impact factor: 6.939

2.  Pericervical Injection of 99mTc-Nanocolloid Is Superior to Peritumoral Injection for Sentinel Lymph Node Detection of Endometrial Cancer in SPECT/CT.

Authors:  Samine Sahbai; Florin-Andrei Taran; Francesco Fiz; Annette Staebler; Sven Becker; Erich Solomayer; Diethelm Wallwiener; Christian la Fougère; Sara Brucker; Helmut Dittmann
Journal:  Clin Nucl Med       Date:  2016-12       Impact factor: 7.794

3.  [Sentinel lymph node diagnosis in prostatic carcinoma: II. Biokinetics and dosimetry of 99mTc-Nanocolloid after intraprostatic injection].

Authors:  H Wengenmair; J Kopp; H Vogt; F Wawroschek; S Gröber; R Dorn; P Heidenreich
Journal:  Nuklearmedizin       Date:  2002-04       Impact factor: 1.379

4.  Sentinel Lymph Node Mapping in Endometrial Cancer: An Update.

Authors:  Fady Khoury-Collado; Caryn St Clair; Nadeem R Abu-Rustum
Journal:  Oncologist       Date:  2016-03-09

5.  Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.

Authors:  J Ferlay; E Steliarova-Foucher; J Lortet-Tieulent; S Rosso; J W W Coebergh; H Comber; D Forman; F Bray
Journal:  Eur J Cancer       Date:  2013-02-26       Impact factor: 9.162

6.  Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion.

Authors:  Ane Gerda Zahl Eriksson; Jen Ducie; Narisha Ali; Michaela E McGree; Amy L Weaver; Giorgio Bogani; William A Cliby; Sean C Dowdy; Jamie N Bakkum-Gamez; Nadeem R Abu-Rustum; Andrea Mariani; Mario M Leitao
Journal:  Gynecol Oncol       Date:  2015-12-31       Impact factor: 5.482

7.  Use of SPECT/CT for improved sentinel lymph node localization in endometrial cancer.

Authors:  A Perissinotti; P Paredes; S Vidal-Sicart; A Torné; S Albela; I Navales; S Martínez-Román; J Pahisa; F Pons
Journal:  Gynecol Oncol       Date:  2013-01-30       Impact factor: 5.482

8.  Tracer injection sites and combinations for sentinel lymph node detection in patients with endometrial cancer.

Authors:  Hitoshi Niikura; Michiko Kaiho-Sakuma; Hideki Tokunaga; Masafumi Toyoshima; Hiroki Utsunomiya; Satoru Nagase; Tadao Takano; Mika Watanabe; Kiyoshi Ito; Nobuo Yaegashi
Journal:  Gynecol Oncol       Date:  2013-08-27       Impact factor: 5.482

9.  Normal appearance and reproducibility of liver-spleen studies with Tc-99m sulfur colloid and Tc-99m microalbumin colloid.

Authors:  W C Klingensmith; V M Spitzer; A R Fritzberg; C C Kuni
Journal:  J Nucl Med       Date:  1983-01       Impact factor: 10.057

10.  Sentinel lymph node biopsy (SLNB) vs. axillary lymph node dissection (ALND) in the current surgical treatment of early stage breast cancer.

Authors:  M Gherghe; C Bordea; A Blidaru
Journal:  J Med Life       Date:  2015 Apr-Jun
View more
  5 in total

1.  Influence of 99m-Tc-Nanocolloid Activity Concentration on Sentinel Lymph Node Detection in Endometrial Cancer: A Quantitative SPECT/CT Study.

Authors:  Samine Sahbai; Francesco Fiz; Florin Taran; Sara Brucker; Diethelm Wallwiener; Juergen Kupferschlaeger; Christian La Fougère; Helmut Dittmann
Journal:  Diagnostics (Basel)       Date:  2020-09-16

2.  Detection of the sentinel lymph node with hybrid tracer (ICG-[99mTc]Tc-albumin nanocolloid) in intermediate- and high-risk endometrial cancer: a feasibility study.

Authors:  Nuria Sánchez-Izquierdo; Sergi Vidal-Sicart; Francisco Campos; Aureli Torné; Martina Aida Angeles; Federico Migliorelli; Meritxell Munmany; Adela Saco; Berta Diaz-Feijoo; Ariel Glickman; Jaume Ordi; Andrés Perissinotti; Marta Del Pino; Pilar Paredes
Journal:  EJNMMI Res       Date:  2021-12-14       Impact factor: 3.138

3.  Multiparametric Dual-Time-Point [18F]FDG PET/MRI for Lymph Node Staging in Patients with Untreated FIGO I/II Cervical Carcinoma.

Authors:  Matthias Weissinger; Stefan Kommoss; Johann Jacoby; Stephan Ursprung; Ferdinand Seith; Sascha Hoffmann; Konstantin Nikolaou; Sara Yvonne Brucker; Christian La Fougère; Helmut Dittmann
Journal:  J Clin Med       Date:  2022-08-23       Impact factor: 4.964

4.  Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer.

Authors:  Hans Nagar; Nina Wietek; Richard J Goodall; Will Hughes; Mia Schmidt-Hansen; Jo Morrison
Journal:  Cochrane Database Syst Rev       Date:  2021-06-09

5.  Positive non-sentinel axillary lymph nodes in breast cancer with 1-2 sentinel lymph node metastases.

Authors:  Jianwei Zheng; Shuyan Cai; Huimin Song; Yunlei Wang; Xiaofeng Han; Haoliang Wu; Zhigang Gao; Fanrong Qiu
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.